Utilization of rapid infusion system with cold saline in the induction of therapeutic hypothermiaSUNG WOONG JIN; YOON HEE CHOI; DONG HOON LEE et al.Journal of international medical research. 2014, Vol 42, Num 3, pp 744-749, issn 0300-0605, 6 p.Article

A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancerYOON HEE CHOI; TAE WON KIM; SUNG SOOK LEE et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 4, pp 905-912, issn 0344-5704, 8 p.Article

Proteomic pattern-based identification of molecular phenotypes from Arabidopsis thaliana ecotypesKYUNG MOK PARK; YOON HEE CHOI; WON MAN PARK et al.Plant science (Limerick). 2009, Vol 177, Num 1, pp 7-18, issn 0168-9452, 12 p.Article

Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in ratsBYUNG HA CHUNG; CAN LI; KIM, Jin et al.American journal of transplantation (Print). 2005, Vol 5, Num 8, pp 1856-1867, issn 1600-6135, 12 p.Article

The similar survival benefits of stable disease and partial response to pemetrexed in previously treated non-small cell carcinoma patientsKIM, Hye-Ryoun; MIN SOO KANG; IM IL NA et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 4, pp 547-552, issn 0171-5216, 6 p.Article

A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02YOON HEE CHOI; SANG CHEUL OH; JEUNG, Hei-Cheul et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 5, pp 665-672, issn 0344-5704, 8 p.Article

A Phase II Study of Clinical Outcomes of 3-Week Cycles of Irinotecan and S-1 in Patients with Previously Untreated Metastatic Colorectal Cancer: Influence of the UGT1A1 and CYP2A6 Polymorphisms on Clinical ActivityYOON HEE CHOI; TAE WON KIM; SHINB, Jae-Gook et al.Oncology. 2012, Vol 82, Num 5, pp 290-297, issn 0030-2414, 8 p.Article

A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinomaINKEUN PARK; RYU, Min-Hee; BYUNG SIK KIM et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 4, pp 815-823, issn 0344-5704, 9 p.Article